0000000302cnt-2013-11_gpc_obesidad-2013

Guía de Práctica Clínica Nacional sobre Diagnóstico y Tratamiento de la Obesidad / Versión preliminar
Guía de Práctica Clínica Nacional sobre Diagnóstico y Tratamiento de la Obesidad / Versión preliminar 141
165. E. E. Acupuncture / acupressure for
weight reduction A systematic review. Wien
Klin Wochenschr. 1997;109(2):60–2.
166. Lacey JM, Tershakovec a M, Foster GD.
Acupuncture for the treatment of obesity: a review
of the evidence. Int. J. Obes. Relat. Metab.
Disord. [Internet]. 2003 Apr [cited 2013 Sep
27];27(4):419–27. Available from: http://www.
ncbi.nlm.nih.gov/pubmed/12664074
167. Cho S-H, Lee J-S, Thabane L. Acupuncture
for obesity: a systematic review and
meta-analysis. Int. J. Obes. (Lond). [Internet].
2009 Feb [cited 2013 Sep 27];33(2):183–96.
Available from: http://www.ncbi.nlm.nih.gov/
pubmed/19139756
168. Onakpoya IJ, Posadzki PP, Watson LK,
Davies LA EE. The efficacy of long-term conjugated
linoleic acid (CLA) supplementation on
body composition in overweight and obese individuals:
a systematic review and meta-analysis
of randomized clinical trials. Eur J Nutr. 2012
Mar;51(2):127-34. Epub 2011 Oct 12. Eur J Nutr.
2012;51(2):127–34.
169. Gaullier J-M, Halse J, Høye K, Kristiansen
K, Fagertun H VH. Conjugated linoleic acid
supplementation for 1 year reduces body fat
mass in healthy overweight humans. Am J Clin
Nutr. 2004;79(6):1118–25.
170. Larsen TM, Toubro S, Gudmundsen O
AA. Conjugated linoleic acid supplementation
for 1 year does not prevent weight or body fat
regain. Am J Clin Nutr. 2006;83(3):606–12.
171. Trowman R, Dumville JC, Hahn S TD.
A systematic review of the effects of calcium
supplementation on body weight. Br J Nutr.
2006;95:1033–8.
172. Cercato C, Roizenblatt VA, Leança CC,
Segal A, Lopes Filho AP, Mancini MC H. A randomized
double-blind placebo-controlled study
of the long-term efficacy and safety of diethylpropion
in the treatment of obese subjects. Int J
Obes. 2009;
173. Haddock CK, Poston WSC, Dill PL, Foreyt
JP, Ericsson M. Pharmacotherapy for obesity:
a quantitative analysis of four decades of published
randomized clinical trials. Int. J. Obes. Relat.
Metab. Disord. [Internet]. 2002 Feb;26(2):262–
73. Available from: http://www.ncbi.nlm.nih.
gov/pubmed/11850760
174. CK Haddock*, WSC Poston1, PL Dill1 JF
and ME. Pharmacotherapy for obesity: a quantitative
analysis of four decades of published randomized
clinical trials. Int. J. Obes. 2002;26:262–
73.
175. Ioannides-Demos LL, Proietto J, Tonkin
AM, McNeil JJ. Safety of drug therapies used
for weight loss and treatment of obesity. Drug
Saf. [Internet]. 2006 Jan;29(4):277–302. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/16569079
176. Delaet D, Schauer D. Search date September
2010 Endocrine and metabolic disorders.
2011;(September 2010):1–25.
177. Etxeberria-Agirre A, Rotaeche del Campo
R, Lekue Alkorta I et al. Descripción de la
metodología de elaboración-adaptación-actualización
empleada en la guía de práctica clínica sobre
asma de la CAPV. Proyecto de Investigación
Comisionada. Vitoria-Gasteiz: Departamento de
Sanidad, Gobierno Vasco. 2005.
178. Mazzei ME, Puchulu MR RM. Tabla de
composición química de los alimentos. Buenos
Aires, Argentina;
179. Varios. Consenso argentino de nutrición
en cirugía bariátrica. Mendoza, Argentina;
2010.